# A Study of Mesenchymal Stem Cell in the Treatment of Autism Spectrum Disorder

> **NCT07177677** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd.** · enrollment: 42 (estimated)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **BIOLOGICAL:** hBMMSC

## Key facts

- **NCT ID:** NCT07177677
- **Lead sponsor:** Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-30
- **Primary completion:** 2026-12-30
- **Final completion:** 2028-08-30
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2025-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07177677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07177677, "A Study of Mesenchymal Stem Cell in the Treatment of Autism Spectrum Disorder". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07177677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*